JP2017502076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017502076A5 JP2017502076A5 JP2016551012A JP2016551012A JP2017502076A5 JP 2017502076 A5 JP2017502076 A5 JP 2017502076A5 JP 2016551012 A JP2016551012 A JP 2016551012A JP 2016551012 A JP2016551012 A JP 2016551012A JP 2017502076 A5 JP2017502076 A5 JP 2017502076A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- cell
- antigen
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019223500A JP6963836B2 (ja) | 2013-11-04 | 2019-12-11 | 数種の神経細胞腫瘍および脳腫瘍に対する個別化免疫療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899680P | 2013-11-04 | 2013-11-04 | |
| GB1319446.9 | 2013-11-04 | ||
| GBGB1319446.9A GB201319446D0 (en) | 2013-11-04 | 2013-11-04 | Personalized immunotherapy against several neuronal and brain tumors |
| US61/899,680 | 2013-11-04 | ||
| PCT/EP2014/073588 WO2015063302A2 (en) | 2013-11-04 | 2014-11-03 | Personalized immunotherapy against several neuronal and brain tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019223500A Division JP6963836B2 (ja) | 2013-11-04 | 2019-12-11 | 数種の神経細胞腫瘍および脳腫瘍に対する個別化免疫療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017502076A JP2017502076A (ja) | 2017-01-19 |
| JP2017502076A5 true JP2017502076A5 (enExample) | 2017-11-02 |
| JP6632982B2 JP6632982B2 (ja) | 2020-01-22 |
Family
ID=49767624
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016551012A Expired - Fee Related JP6632982B2 (ja) | 2013-11-04 | 2014-11-03 | 数種の神経細胞腫瘍および脳腫瘍に対する個別化免疫療法 |
| JP2021129398A Active JP7426972B2 (ja) | 2013-11-04 | 2021-08-05 | 数種の神経細胞腫瘍および脳腫瘍に対する個別化免疫療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021129398A Active JP7426972B2 (ja) | 2013-11-04 | 2021-08-05 | 数種の神経細胞腫瘍および脳腫瘍に対する個別化免疫療法 |
Country Status (27)
| Country | Link |
|---|---|
| US (9) | US10946064B2 (enExample) |
| EP (3) | EP3539979A3 (enExample) |
| JP (2) | JP6632982B2 (enExample) |
| KR (3) | KR102414447B1 (enExample) |
| CN (3) | CN105793280B (enExample) |
| AU (3) | AU2014343599B2 (enExample) |
| BR (1) | BR112016009402A2 (enExample) |
| CA (1) | CA2929445A1 (enExample) |
| CU (1) | CU20160060A7 (enExample) |
| CY (1) | CY1121691T1 (enExample) |
| DK (1) | DK3066115T3 (enExample) |
| EA (1) | EA036517B1 (enExample) |
| ES (1) | ES2733517T3 (enExample) |
| GB (1) | GB201319446D0 (enExample) |
| HR (1) | HRP20191009T1 (enExample) |
| HU (1) | HUE045038T2 (enExample) |
| LT (1) | LT3066115T (enExample) |
| ME (1) | ME03458B (enExample) |
| MX (1) | MX379423B (enExample) |
| PL (1) | PL3066115T3 (enExample) |
| PT (1) | PT3066115T (enExample) |
| RS (1) | RS59031B1 (enExample) |
| SG (2) | SG10201900727QA (enExample) |
| SI (1) | SI3066115T1 (enExample) |
| TR (1) | TR201909021T4 (enExample) |
| UA (1) | UA124048C2 (enExample) |
| WO (1) | WO2015063302A2 (enExample) |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| TWI777195B (zh) * | 2013-08-05 | 2022-09-11 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（三） |
| MX2019013161A (es) * | 2013-11-04 | 2020-02-03 | Immatics Biotechnologies Gmbh | Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales. |
| EP3092049A1 (en) | 2014-01-08 | 2016-11-16 | Flodesign Sonics Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| US10000533B2 (en) | 2014-06-20 | 2018-06-19 | Immatics Biotechnologies Gmbh | Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) |
| HUE052106T2 (hu) * | 2015-04-27 | 2021-04-28 | Cancer Research Tech Ltd | Eljárás rák kezelésére |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| GB201507719D0 (en) * | 2015-05-06 | 2015-06-17 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers |
| CR20230131A (es) | 2015-05-06 | 2023-06-23 | Immatics Biotechnologies Gmbh | NUEVOS PÉPTIDOS Y NUEVAS COMBINACIONES DE PÉPTIDOS Y DE SOPORTES PARA LA INMUNOTERAPIA CONTRA EL CARCINOMA COLORRECTAL Y OTROS TIPOS DE CÁNCER (Divisional Exp. 2017-0497) |
| IL292697A (en) * | 2015-06-19 | 2022-07-01 | Immatics Biotechnologies Gmbh | New peptides and their combination for use in immunotherapy and methods for creating supports for use against pancreatic cancer and other types of cancer |
| EA201792671A1 (ru) | 2015-07-06 | 2018-06-29 | Имматикс Байотекнолоджиз Гмбх | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака пищевода и других видов рака |
| GB201512369D0 (en) * | 2015-07-15 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| CN105092859B (zh) * | 2015-08-04 | 2016-09-14 | 中国农业大学 | Net49蛋白作为糖尿病生物标记物及治疗靶点的应用 |
| GB201513921D0 (en) | 2015-08-05 | 2015-09-23 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers |
| GB201516047D0 (en) | 2015-09-10 | 2015-10-28 | Cancer Rec Tech Ltd | Method |
| PH12022551111A1 (en) | 2015-10-05 | 2023-08-23 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
| GB201520567D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| WO2017095632A1 (en) | 2015-11-30 | 2017-06-08 | Mayo Foundation For Medical Education And Research | Heatr1 as a marker for chemoresistance |
| GB201521746D0 (en) | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| GB201521894D0 (en) | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| US10383896B2 (en) | 2015-12-11 | 2019-08-20 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against various cancers |
| HK1255541A1 (zh) | 2015-12-11 | 2019-08-23 | Immatics Biotechnologies Gmbh | 用於多种癌症免疫治疗的新型肽和肽组合物 |
| EP4299136A3 (en) | 2015-12-16 | 2024-02-14 | Gritstone bio, Inc. | Neoantigen identification, manufacture, and use |
| HRP20210698T1 (hr) * | 2015-12-22 | 2021-09-17 | Immatics Biotechnologies Gmbh | Peptidi i kombinacija peptida za uporabu u imunoterapiji protiv karcinoma dojke i drugih karcinoma |
| GB201522667D0 (en) * | 2015-12-22 | 2016-02-03 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers |
| GB201603568D0 (en) * | 2016-03-01 | 2016-04-13 | Immatics Biotechnologies Gmbh | Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer |
| GB201603987D0 (en) | 2016-03-08 | 2016-04-20 | Immatics Biotechnologies Gmbh | Uterine cancer treatments |
| ES2930681T3 (es) * | 2016-03-16 | 2022-12-20 | Immatics Biotechnologies Gmbh | Linfocitos T transfectados y receptores de linfocito T para el uso en la inmunoterapia contra el cáncer |
| GB201604494D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers |
| GB201604490D0 (en) | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides combination of peptides for use in immunotherapy against cancers |
| GB201604458D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against cancers |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| WO2017194170A1 (en) | 2016-05-13 | 2017-11-16 | Biontech Rna Pharmaceuticals Gmbh | Methods for predicting the usefulness of proteins or protein fragments for immunotherapy |
| JP7075125B2 (ja) | 2016-05-25 | 2022-05-25 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ |
| GB201609193D0 (en) | 2016-05-25 | 2016-07-06 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers |
| TWI796299B (zh) * | 2016-08-26 | 2023-03-21 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| RU2019119272A (ru) * | 2016-11-23 | 2020-12-24 | Гритстоун Онколоджи, Инк. | Вирусная доставка неоантигенов |
| EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| PE20191248A1 (es) | 2017-01-27 | 2019-09-18 | Immatics Biotechnologies Gmbh | Nuevos peptidos y nuevas combinaciones de peptidos para el uso en la inmunoterapia contra el cancer de ovario y otros tipos de cancer |
| AR110857A1 (es) | 2017-01-27 | 2019-05-08 | Immatics Biotechnologies Gmbh | Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer |
| WO2018138257A1 (en) * | 2017-01-27 | 2018-08-02 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| BR112019015797A2 (pt) | 2017-02-01 | 2020-03-17 | Modernatx, Inc. | Composições de mrna terapêuticas imunomoduladoras que codificam peptídeos de mutação de oncogene de ativação |
| EA201992416A1 (ru) | 2017-04-10 | 2020-02-25 | Имматикс Байотекнолоджиз Гмбх | Пептиды и комбинации пептидов для применения в иммунотерапии лейкозов и других видов рака |
| US11427614B2 (en) | 2017-04-10 | 2022-08-30 | Immatics Biotechnologies Gmbh | Peptides and combination thereof for use in the immunotherapy against cancers |
| CR20190509A (es) | 2017-04-10 | 2020-01-08 | Immatics Biotechnologies Gmbh | Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra la leucemia y otros tipos de cáncer |
| AU2018251839B2 (en) * | 2017-04-10 | 2022-06-30 | Immatics Biotechnologies Gmbh | Peptides and combination thereof for use in the immunotherapy against cancers |
| AU2018266705B2 (en) | 2017-05-08 | 2023-05-04 | Seattle Project Corp. | Alphavirus neoantigen vectors |
| WO2018212237A1 (ja) * | 2017-05-16 | 2018-11-22 | 学校法人 久留米大学 | テーラーメイド型ペプチドワクチン剤に対する脳腫瘍患者の適格性を判定する方法 |
| WO2019007974A1 (en) | 2017-07-07 | 2019-01-10 | Immatics Biotechnologies Gmbh | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NSCLC, CPPC AND OTHER CANCERS |
| AU2018297578C1 (en) | 2017-07-07 | 2022-06-09 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers |
| EP3694532B1 (en) | 2017-10-10 | 2025-02-26 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
| IL274799B2 (en) | 2017-11-22 | 2025-05-01 | Gritstone Bio Inc | Reducing junction epitope presentation for neoantigens |
| BR112020009889A2 (pt) | 2017-12-14 | 2020-11-03 | Flodesign Sonics, Inc. | acionador e controlador de transdutor acústico |
| CN118955720A (zh) | 2018-01-04 | 2024-11-15 | 伊科尼克治疗公司 | 抗组织因子抗体、抗体-药物缀合物及相关方法 |
| DE102018107224A1 (de) | 2018-02-21 | 2019-08-22 | Immatics Biotechnologies Gmbh | Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten |
| CN108623661B (zh) * | 2018-05-14 | 2021-04-27 | 中国医学科学院肿瘤医院 | 一种靶向胰腺癌肿瘤细胞的双特异性多肽分子探针及应用 |
| TW202016131A (zh) | 2018-05-16 | 2020-05-01 | 德商英麥提克生物技術股份有限公司 | 用於抗癌免疫治療的肽 |
| US12480940B2 (en) | 2018-05-17 | 2025-11-25 | Meso Scale Technologies, Llc. | Methods for isolating surface marker displaying agents |
| US10925947B2 (en) | 2018-06-29 | 2021-02-23 | Immatics Biotechnologies Gmbh | A*03 restricted peptides for use in immunotherapy against cancers and related methods |
| DE102018115865A1 (de) * | 2018-06-29 | 2020-02-20 | Immatics Biotechnologies Gmbh | A*03-restringierte Peptide zur Verwendung in der Immuntherapie gegen Krebs und verwandte Verfahren |
| WO2020020444A1 (en) * | 2018-07-24 | 2020-01-30 | Biontech Rna Pharmaceuticals Gmbh | Individualized vaccines for cancer |
| US11945850B2 (en) | 2018-09-17 | 2024-04-02 | Immatics Biotechnologies Gmbh | B*44 restricted peptides for use in immunotherapy against cancers and related methods |
| TW202024121A (zh) | 2018-09-18 | 2020-07-01 | 德商英麥提克生物技術股份有限公司 | A*01 限制肽和肽組合物在抗癌免疫治療中的用途和相關方法 |
| TW202039535A (zh) | 2018-12-18 | 2020-11-01 | 德商英麥提克生物技術股份有限公司 | B*08限制肽和肽組合物抗癌免疫治療和相關方法 |
| CN109706065A (zh) * | 2018-12-29 | 2019-05-03 | 深圳裕策生物科技有限公司 | 肿瘤新生抗原负荷检测装置及存储介质 |
| CN109750040B (zh) * | 2019-03-05 | 2023-05-12 | 上海市第七人民医院 | Heatr1基因或蛋白的抑制剂在制备抗肿瘤药物中的应用 |
| BR112021024127A2 (pt) | 2019-05-30 | 2022-04-26 | Gritstone Bio Inc | Adenovírus modificado |
| US12036204B2 (en) | 2019-07-26 | 2024-07-16 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition for treating tumor |
| US20230204565A1 (en) * | 2020-01-02 | 2023-06-29 | The Regents Of The University Of California | Methods for Culturing Cancer Cells and for Inhibiting Invasion of Cancer |
| GR1010022B (el) * | 2020-03-17 | 2021-06-01 | Πανεπιστημιο Πατρων | Μεθοδοι για προσδιορισμο της προγνωσης της επιβιωσης ενος ατομου με αδενοκαρκινωμα πνευμονα και της ανταποκρισης στη θεραπεια |
| CN113493835A (zh) * | 2020-03-20 | 2021-10-12 | 上海鹍远健康科技有限公司 | 通过检测bcan基因区域的甲基化状态筛查大肠瘤的方法和试剂盒 |
| CN116438308A (zh) | 2020-08-06 | 2023-07-14 | 磨石生物公司 | 多表位疫苗盒 |
| CN112053785A (zh) * | 2020-09-02 | 2020-12-08 | 北京小白世纪网络科技有限公司 | 基于冠心病诊断神经网络模型冠心病诊断方法及系统 |
| WO2022051481A2 (en) * | 2020-09-04 | 2022-03-10 | Meso Scale Technologies, Llc. | Methods for isolating central nervous system surface marker displaying agents |
| CN112946279A (zh) * | 2021-03-17 | 2021-06-11 | 扬州大学 | 一种基于油水界面自组装的三明治sers免疫传感器检测宫颈癌患者血清生物标志物方法 |
| CN114022472B (zh) * | 2021-11-17 | 2022-05-20 | 深圳裕策生物科技有限公司 | 一种肿瘤浸润淋巴细胞分析方法、装置和存储介质 |
| CN114231494B (zh) * | 2021-11-29 | 2023-09-05 | 中国科学院动物研究所 | USP10基因和/或Ascl1基因在诱导成纤维细胞转分化为神经元细胞的应用及方法 |
| CN114146180B (zh) * | 2021-12-22 | 2022-12-23 | 首都医科大学附属北京地坛医院 | 抑制chchd2活性的物质在制备治疗nash和肝损伤所致肝纤维化的产品中的应用 |
| US20230377140A1 (en) * | 2022-02-01 | 2023-11-23 | 4D Path Inc. | Systems and Methods for Image-Based Disease Characterization |
| WO2023213904A1 (en) * | 2022-05-04 | 2023-11-09 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | T cell receptor derived binding polypeptides |
| EP4382121A1 (en) * | 2022-12-07 | 2024-06-12 | Altevax | Vaccines against ptprz1-positive tumors |
| WO2024231899A1 (en) * | 2023-05-10 | 2024-11-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Compounds for nos-related cancers and methods of use |
| CN116808017B (zh) * | 2023-07-19 | 2025-10-17 | 清华大学 | 非瑟酮在预防/治疗kif1a相关的神经疾病中的用途 |
| WO2025103803A1 (en) * | 2023-11-13 | 2025-05-22 | CureVac SE | Immunotherapy against neuronal and brain tumors |
| CN119827767B (zh) * | 2025-01-14 | 2025-10-28 | 重庆医科大学 | 泛素特异性蛋白酶usp4在治疗急性肺损伤/急性呼吸窘迫综合征中的应用 |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2000E (fr) | 1901-04-20 | 1903-11-24 | Albert Lagarde | Cadre pliant en fer pour le transport en wagons des fruits et primeurs |
| US3119139A (en) | 1961-02-06 | 1964-01-28 | Taylor Mfg | Bottle case inverter |
| DE2148469A1 (de) | 1971-09-28 | 1973-04-05 | Ullrich G Messwerkzeug Kg | Wasserwaage mit einer im winkel einstellbaren libelle |
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| IN151589B (enExample) | 1978-12-22 | 1983-05-28 | Biogen Nv | |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| US4897445A (en) | 1986-06-27 | 1990-01-30 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide bond |
| AU6852594A (en) | 1993-06-03 | 1995-01-03 | Therapeutic Antibodies Inc. | Production of antibody fragments |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| WO1997026328A1 (en) | 1996-01-17 | 1997-07-24 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
| US5849589A (en) | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6514935B1 (en) * | 1997-03-14 | 2003-02-04 | President And Fellows Of Harvard | Methods of treating hypertension |
| US7030235B1 (en) * | 1998-09-29 | 2006-04-18 | The Brigham & Women's Hospital, Inc. | Compositions to detect lesions associated with hearing loss in the cochlear gene, COCH5B2 |
| EP1290217A2 (en) * | 2000-02-04 | 2003-03-12 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| ATE472601T1 (de) | 2000-03-27 | 2010-07-15 | Technion Res And Dev Of Founda | Einkettige haupthistokompatibilitätskomplexe der klasse i (mhc-i), kodierende konstrukte und methoden ihrer erzeugung |
| US20040191260A1 (en) | 2003-03-26 | 2004-09-30 | Technion Research & Development Foundation Ltd. | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof |
| CN1464790A (zh) | 2000-06-05 | 2003-12-31 | 苏诺尔分子公司 | T细胞受体融合物及共轭物以及其使用方法 |
| GB0017512D0 (en) * | 2000-07-17 | 2000-08-30 | Smithkline Beecham Biolog | Novel compounds |
| JP2004537282A (ja) * | 2001-03-23 | 2004-12-16 | エージーワイ セラピューティクス | 脳腫瘍の処置及び可視化における生体分子標的の使用法 |
| EP2000545B1 (en) * | 2001-06-20 | 2011-08-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of lung tumor |
| US7803915B2 (en) * | 2001-06-20 | 2010-09-28 | Genentech, Inc. | Antibody compositions for the diagnosis and treatment of tumor |
| WO2003016475A2 (en) * | 2001-08-14 | 2003-02-27 | The General Hospital Corporation | Nucleic acid and amino acid sequences involved in pain |
| US6992176B2 (en) | 2002-02-13 | 2006-01-31 | Technion Research & Development Foundation Ltd. | Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| US20030223994A1 (en) | 2002-02-20 | 2003-12-04 | Hoogenboom Henricus Renerus Jacobus Mattheus | MHC-peptide complex binding ligands |
| JP4436319B2 (ja) | 2002-10-09 | 2010-03-24 | メディジーン リミテッド | 単鎖組換えｔ細胞レセプター |
| DE60327795D1 (de) | 2002-11-09 | 2009-07-09 | Immunocore Ltd | T zell rezeptor "display" |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| JP2005245430A (ja) * | 2003-08-25 | 2005-09-15 | Medeinetto:Kk | Ｃｔｌの誘導方法 |
| WO2006034334A2 (en) | 2004-09-21 | 2006-03-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| EP1859266A4 (en) * | 2005-02-24 | 2010-07-28 | Cemines Inc | COMPOSITIONS AND METHODS FOR CLASSIFYING BIOLOGICAL SAMPLES |
| ATE461215T1 (de) | 2005-09-05 | 2010-04-15 | Immatics Biotechnologies Gmbh | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden |
| US9500048B2 (en) | 2006-05-09 | 2016-11-22 | Comacchio International S.A. | Drilling machine with carousel-type drill stem and shroud tube loader |
| HRP20150820T1 (xx) | 2007-07-27 | 2015-09-11 | Immatics Biotechnologies Gmbh | Nova imunoterapija protiv neuronskih tumora i tumora mozga |
| PL2562182T3 (pl) * | 2007-07-27 | 2016-03-31 | Immatics Biotechnologies Gmbh | Nowe immunogenne epitopy do immunoterapii |
| CN101648012A (zh) * | 2008-04-24 | 2010-02-17 | 伊玛提克斯生物技术有限公司 | 结合到人类白细胞抗原(hla)ⅰ类或ⅱ类分子上用作疫苗的肿瘤相关肽新制剂 |
| DE602008000891D1 (de) | 2008-04-30 | 2010-05-12 | Immatics Biotechnologies Gmbh | Neuartige Formulierungen von Tumor-assoziierten Peptiden, welche an menschliche Leukozytenantigene der Klasse I oder II für Impfungen binden |
| EP2119726B2 (en) | 2008-05-14 | 2017-11-29 | Immatics Biotechnologies GmbH | Novel and powerful MHC-class II peptides derived from survivin and neurocan |
| EP2172211B1 (en) | 2008-10-01 | 2014-12-03 | Immatics Biotechnologies GmbH | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| WO2011051278A1 (en) * | 2009-10-26 | 2011-05-05 | Externautics S.P.A. | Lung tumor markers and methods of use thereof |
| WO2011051276A1 (en) * | 2009-10-26 | 2011-05-05 | Externautics S.P.A. | Colon and rectal tumor markers and methods of use thereof |
| GB201006360D0 (en) | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| US20130310266A1 (en) * | 2010-09-03 | 2013-11-21 | Immport Therapeutics, Inc. | Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders |
| WO2012056407A1 (en) | 2010-10-26 | 2012-05-03 | Technion Research & Development Foundation Ltd. | Antibodies which bind soluble t-cell receptor ligands |
| US9103183B2 (en) | 2011-08-03 | 2015-08-11 | Vetco Gray Inc. | Method and apparatus for launching multiple balls in a well |
| WO2013057586A1 (en) | 2011-10-19 | 2013-04-25 | Oslo Universitetssykehus Hf | Compositions and methods for producing soluble t - cell receptors |
| WO2013071295A2 (en) * | 2011-11-10 | 2013-05-16 | Rutgers, The State University Of New Jersey | Transcript optimized expression enhancement for high-level production of proteins and protein domains |
| PT3149048T (pt) * | 2014-05-28 | 2020-04-21 | Nono Inc | Formulação liofilizada de tat-nr2b9c |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
-
2013
- 2013-11-04 GB GBGB1319446.9A patent/GB201319446D0/en not_active Ceased
-
2014
- 2014-11-03 AU AU2014343599A patent/AU2014343599B2/en not_active Ceased
- 2014-11-03 LT LTEP14792834.5T patent/LT3066115T/lt unknown
- 2014-11-03 RS RS20190775A patent/RS59031B1/sr unknown
- 2014-11-03 ES ES14792834T patent/ES2733517T3/es active Active
- 2014-11-03 US US14/531,472 patent/US10946064B2/en not_active Expired - Fee Related
- 2014-11-03 KR KR1020167014775A patent/KR102414447B1/ko active Active
- 2014-11-03 EP EP19166517.3A patent/EP3539979A3/en not_active Withdrawn
- 2014-11-03 JP JP2016551012A patent/JP6632982B2/ja not_active Expired - Fee Related
- 2014-11-03 TR TR2019/09021T patent/TR201909021T4/tr unknown
- 2014-11-03 KR KR1020217016805A patent/KR102415748B1/ko active Active
- 2014-11-03 EP EP23176827.6A patent/EP4253401A3/en not_active Withdrawn
- 2014-11-03 SG SG10201900727QA patent/SG10201900727QA/en unknown
- 2014-11-03 CN CN201480059678.5A patent/CN105793280B/zh active Active
- 2014-11-03 DK DK14792834.5T patent/DK3066115T3/da active
- 2014-11-03 HR HRP20191009TT patent/HRP20191009T1/hr unknown
- 2014-11-03 BR BR112016009402A patent/BR112016009402A2/pt not_active IP Right Cessation
- 2014-11-03 CN CN202010054632.1A patent/CN111303244B/zh active Active
- 2014-11-03 UA UAA201604922A patent/UA124048C2/uk unknown
- 2014-11-03 PT PT14792834T patent/PT3066115T/pt unknown
- 2014-11-03 SG SG11201603299PA patent/SG11201603299PA/en unknown
- 2014-11-03 KR KR1020227021113A patent/KR102651028B1/ko active Active
- 2014-11-03 SI SI201431228T patent/SI3066115T1/sl unknown
- 2014-11-03 EA EA201690868A patent/EA036517B1/ru unknown
- 2014-11-03 CN CN202410875965.9A patent/CN118852353A/zh active Pending
- 2014-11-03 EP EP14792834.5A patent/EP3066115B1/en active Active
- 2014-11-03 MX MX2016005866A patent/MX379423B/es unknown
- 2014-11-03 WO PCT/EP2014/073588 patent/WO2015063302A2/en not_active Ceased
- 2014-11-03 CA CA2929445A patent/CA2929445A1/en active Pending
- 2014-11-03 PL PL14792834T patent/PL3066115T3/pl unknown
- 2014-11-03 HU HUE14792834A patent/HUE045038T2/hu unknown
- 2014-11-03 ME MEP-2019-193A patent/ME03458B/me unknown
-
2016
- 2016-05-04 CU CUP2016000060A patent/CU20160060A7/es unknown
-
2019
- 2019-03-06 AU AU2019201558A patent/AU2019201558B2/en not_active Ceased
- 2019-06-27 CY CY20191100670T patent/CY1121691T1/el unknown
-
2020
- 2020-11-19 AU AU2020273312A patent/AU2020273312B2/en not_active Ceased
-
2021
- 2021-02-02 US US17/165,638 patent/US11607446B2/en active Active
- 2021-07-30 US US17/390,583 patent/US11890333B2/en active Active
- 2021-07-30 US US17/390,584 patent/US11890334B2/en active Active
- 2021-08-05 JP JP2021129398A patent/JP7426972B2/ja active Active
-
2022
- 2022-06-28 US US17/851,417 patent/US11759507B2/en active Active
- 2022-06-28 US US17/852,207 patent/US11529401B2/en active Active
- 2022-06-28 US US17/852,206 patent/US11529400B1/en active Active
- 2022-06-28 US US17/852,205 patent/US11524059B2/en active Active
-
2023
- 2023-03-03 US US18/178,055 patent/US20230263873A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017502076A5 (enExample) | ||
| JP2018510628A5 (enExample) | ||
| JP2018529320A5 (enExample) | ||
| JP2021168652A5 (enExample) | ||
| JP2018511321A5 (enExample) | ||
| JP2019510465A5 (enExample) | ||
| JP2018509135A5 (enExample) | ||
| JP2018518937A5 (enExample) | ||
| CN109152830B (zh) | 用于免疫疗法的核/壳结构平台 | |
| JP2019502360A5 (enExample) | ||
| JP6929867B2 (ja) | がんに対する免疫療法で使用するための形質移入ｔ細胞およびｔ細胞受容体 | |
| JP2012504393A5 (enExample) | ||
| JP2017525336A5 (enExample) | ||
| JP2023055722A (ja) | 非小細胞肺がんおよびその他のがんに対する免疫療法で使用するためのペプチドおよびペプチド組み合わせ | |
| JP2018520653A5 (enExample) | ||
| JP2018536383A5 (enExample) | ||
| RU2017137142A (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака | |
| JP2019506838A5 (enExample) | ||
| JP2018519243A5 (enExample) | ||
| JP2019511214A5 (enExample) | ||
| JP2024099580A5 (enExample) | ||
| JP2024041841A5 (enExample) | ||
| JP2018521641A5 (enExample) | ||
| JP2018518956A5 (enExample) | ||
| JP2017524337A5 (enExample) |